← Leaderboards
Richard Thomas O'Neil
Veterans Health Administration
$0
Attributed
$0
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2019–25$1$1$1$0$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 2
By mechanism
I01$0 · 1
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Veterans Health Administration
Same institution · by research overlap
- Marlene A. Wilson$2,543,075
- Michael Daniel Green$877,372
- Kristie D Goughenour$0
Others in their field
Other Emerging Leaders on “Mortality”
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Yunda Huang · Fred Hutchinson Cancer Center$19,033,873
- Barbara Halina Braffett · George Washington University$17,931,151
Research focus
MortalitySolid NeoplasmEngineered T CellsMalignant NeoplasmsPeptidesResponseChronicClinical TrialsEngraftmentMalignant Neoplasm Of LungNovel TherapeuticsCancer ModelCancer TherapyProtocols DocumentationAnti-CancerChemotherapyCellsCell TherapyCytokineEngineeringImmuneLung NeoplasmsAdoptive TransferTargeted Delivery
Grant awards (6)
Immune modulating T cell therapy for lung cancer$0
I01 · FY2025 · VA · contact PI
Blocking lung cancer progression with peptide delivering cell therapy platforms$0
IK2 · FY2023 · VA · contact PI
Blocking lung cancer progression with peptide delivering cell therapy platforms$0
IK2 · FY2022 · VA · contact PI
Blocking lung cancer progression with peptide delivering cell therapy platforms$0
IK2 · FY2021 · VA · contact PI
Blocking lung cancer progression with peptide delivering cell therapy platforms$0
IK2 · FY2020 · VA · contact PI
Blocking lung cancer progression with peptide delivering cell therapy platforms$0
IK2 · FY2019 · VA · contact PI